AMAG Pharmaceuticals (AMAG)
AMAG Pharmaceuticals Income Statement
- Quarterly: March 2012 - December 2009 Previous Quarters
- Annual
| Income | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Revenue | 15.48M | 14.91M | 17.56M | 15.40M | 13.38M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Cost of Revenue | 2.646M | 2.739M | 2.669M | 2.082M | 3.041M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Gross Profit | 12.83M | 12.17M | 14.89M | 13.32M | 10.34M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Research & Development Expense | 12.46M | 12.98M | 14.89M | 16.70M | 13.57M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Selling, General, & Admin. Expense | 13.18M | 15.17M | 17.23M | 16.83M | 19.63M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Depreciation & Amortization | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Operating Interest Expense | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Other Operating Income (Expense) | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Total Operating Expenses | 28.29M | 34.40M | 34.79M | 35.60M | 36.24M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Operating Income | -12.81M | -19.50M | -17.24M | -20.20M | -22.86M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Non-Operating Income | 0.393M | 0.358M | 0.392M | 0.243M | 0.561M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Pretax Income | -12.42M | -19.14M | -16.85M | -19.96M | -22.30M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Provision for Income Taxes | -0.559M | -0.215M | -0.396M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | ||
| Income after Tax | -12.42M | -18.58M | -16.63M | -19.56M | -22.30M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Minority Interest | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Minority Interest | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Equity In Affiliates | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Income Before Extraordinaries & Disc. Operations | -12.42M | -18.58M | -16.63M | -19.56M | -22.30M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Investment Gains/Losses | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Other Income/Charges | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Income from Discontinued Operations | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Net Income | -12.42M | -18.58M | -16.63M | -19.56M | -22.30M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Earnings Per Share Data | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Average Shares to compute diluted EPS | 21.35 | 21.19 | 21.19 | 21.17 | 21.14 | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Average Shares used to compute basic EPS | 21.35 | 21.19 | 21.19 | 21.17 | 21.14 | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| EPS - Basic net | -0.58 | -0.89 | -0.78 | -0.92 | -1.05 | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| EPS - Diluted net | -0.58 | -0.89 | -0.78 | -0.92 | -1.05 | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
